← Eichor
Study identifier: NCT07270016 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Pilot-Testing Real-Time Engagement for Learning to Effectively Control Type 2 Diabetes

Condition: Diabetes Mellitus, Type 2 · Hyperglycemia · Physical Inactivity  ·  Sponsor: University of Pittsburgh

PhaseNA
Planned participants30
Who can joinAll sexes, 16 Years to 24 Years
Healthy volunteersNo

About this study

The goal of this study is to pilot test features of a new smartphone app and to gather feedback related to wearing a continuous glucose monitor (CGM) and a Fitbit device, as well as to obtain input on health behavior-focused messages delivered through the app. The study will enroll English-speaking participants aged 16-24 years who were diagnosed with type 2 diabetes before age 18. Participants will be asked to fill out surveys about diabetes, physical activity, and diet before and after wearing a CGM for 30 days. At the end of wearing the CGM, participants will complete an interview about their experience.

This description comes directly from the study's public registry record.

Talk to the study team

Mary Ellen Vajravelu, MD, MSHP  ·  4126926533  ·  maryellen.vajravelu@pitt.edu

Always discuss trial participation with your own doctor first.

Locations (1)

Children's Hospital of PittsburghPittsburgh, Pennsylvania, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07270016